RecruitingNot ApplicableNCT05412069

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

A Multicenter, Prospective, Non-randomized Study on Pathophysiology, Diagnosis, and Biofeedback Therapy in Fecal Incontinence (FI) Using Fecobionics (NORMAL and ABNORMAL-FI)


Sponsor

The California Medical Innovations Institute, Inc.

Enrollment

155 participants

Start Date

Feb 15, 2023

Study Type

INTERVENTIONAL

Summary

The objective is to determine the length-tension properties of the anal sphincters using Fecobionics in normal subjects and FI patients during anal distension and during simulated evacuation. Fecobionics has the consistency and shape of normal stool and can record pressures, cross-sectional area, orientation and viscoelastic properties of the anorectum and can map the geometric profiles during evacuation, and thereby provides multi-dimensional measurements of pressures, deformability, and topographic changes. Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as much as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal. The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. It exceeds previous attempts to make artificial stool for evaluation of defecation (BET and FECOM) and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of normal subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • Subject must provide written informed consent;
  • Willing and able to undergo required study tests, surveys, and procedures;
  • Age > 18 years of age.

Exclusion Criteria5

  • Female who is pregnant;
  • Prior anorectal surgery;
  • Prior bowel resection;
  • History of chronic constipation;
  • In the opinion of the investigator, the subject is not a suitable candidate for the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFecobionics

Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry, balloon expulsion test, and anal ultrasonography will be used as reference.


Locations(2)

California Medical Innovations Institute

San Diego, California, United States

Augusta University Medical Center

Augusta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05412069